« Back
Home /
DO3A tert-Butyl ester

DO3A tert-Butyl ester

Item no.	HY-12692-200mg
Manufacturer	MedChem Express
CASRN	122555-91-3
Amount	200 mg
Quantity options	100 mg 10 g 10 mM/1 mL 1 g 200 mg 250 mg 500 mg 5 g
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.0
Citations	[1]Martha L Gilbert, et al. A new synthetic route to 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane. doi:10.1016/S0040-4039(00)73873-1\|[2]Kahnt M, et al., Synthesis and Cytotoxicity Evaluation of DOTA-Conjugates of Ursolic Acid. Molecules. 2019 Jun 17;24(12):2254.
Smiles	O=C(OC(C)(C)C)CN1CCN(CC(OC(C)(C)C)=O)CCNCCN(CC(OC(C)(C)C)=O)CC1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	DO3A tert-butyl,DO3A-t-Bu-ester
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Targets	Drug Derivative
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	514.70
Product Description	DOTA tert-Butyl ester is a cyclic tosamide benzyl derivative.
Manufacturer - Research Area	Cancer
Solubility	DMSO: 62.5 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturer - Pathway	Others
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12692-200mg-safety-datasheet.pdf